行情

BMY

BMY

百时美施贵宝
NYSE

实时行情|Nasdaq Last Sale

56.48
-1.17
-2.03%
已收盘, 19:59 11/19 EST
开盘
57.84
昨收
57.65
最高
57.85
最低
56.26
成交量
3,924.94万
成交额
--
52周最高
59.18
52周最低
42.48
市值
920.06亿
市盈率(TTM)
16.32
分时
5日
1月
3月
1年
5年

分析师评级

12位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

BMY 新闻

  • 百时美施贵宝中国区换帅
  • 界面.2小时前
  • Celgene: Bargain Bin At Bristol-Myers Squibb Deal Closing
  • Seeking Alpha - Article.12小时前
  • Thermo Fisher Scientific Set to Join S&P 100; ServiceNow to Join S&P 500
  • PR Newswire.18小时前
  • ‘Hipster Antitrust’ Might End the Megamerger Party
  • Bloomberg.19小时前

更多

所属板块

制药
+0.40%
制药与医学研究
+0.78%

热门股票

名称
价格
涨跌幅

BMY 简况

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.
展开

Webull提供Bristol-Myers Squibb Co的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。